𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice

✍ Scribed by Cartesio Favalli; Antonio Mastino; Teresa Jezzi; Sandro Grelli; Allan L. Goldstein; Enrico Garaci

Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
632 KB
Volume
11
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic anti-tumor effects of combin
Synergistic anti-tumor effects of combined IL-1/IFN-α/β therapy in mice injected with met astatic friend erythroleukemia cells
✍ F. Belardelli; L. Gabriele; E. Proietti; P. Sestili; M. Peretti; C. Rozera; I. G 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 509 KB

## Abstract Peritumoral injection of relatively low doses of either mouse interferon (IFN)‐α/β (10,000‐20,000 unit/injection) or of recombinant human interleukin‐I (IL‐1) β (125‐250 ng/ injection) in mice transplanted S.C. with Friend erythroleukemia cells (FLC) resulted in some inhibition of prima

The synergistic antitumor effect of reco
The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice
✍ Takehisa Harada; Norimichi Kan; You Ichinose; Yoshio Moriguchi; Li Li; Tomoharu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

## Abstract Intraperitoneal (i. p.) treatment of MOPC104E ascitic tumor‐bearing BALB/c mice with interleukin‐1 (IL‐1) followed by a low dose of cyclophosphamide (CPA) resulted in synergistic prolongation of their survival time. This antitumor effect was abolished when administration of CPA preceded